A Sambugaro, M Donini, E Chistè, M Scarpa… - Journal of Drug Delivery …, 2024 - Elsevier
In this work we report a first-time combination of porous silicon (pSi) particles with the
immunologic adjuvant Pam3CSK4, a TLR 1/2 agonist, as a tool for immunotherapy. pSi is a …